100 related articles for article (PubMed ID: 9010095)
21. Frequent amplification of the c-met gene in scirrhous type stomach cancer.
Kuniyasu H; Yasui W; Kitadai Y; Yokozaki H; Ito H; Tahara E
Biochem Biophys Res Commun; 1992 Nov; 189(1):227-32. PubMed ID: 1333188
[TBL] [Abstract][Full Text] [Related]
22. Detection of C-erb B2 gene amplification in bilharzial associated bladder cancer using fluorescence in situ hybridization.
Aly MS; Khaled HM
Urol Oncol; 2004; 22(6):448-52. PubMed ID: 15610859
[TBL] [Abstract][Full Text] [Related]
23. Increased proliferative activity caused by loss of p21(WAF1/CIP1) expression and its clinical significance in patients with early-stage gastric carcinoma.
Noda H; Maehara Y; Irie K; Kakeji Y; Yonemura T; Sugimachi K
Cancer; 2002 Apr; 94(7):2107-12. PubMed ID: 11932915
[TBL] [Abstract][Full Text] [Related]
24. [Relationship between PD-L1 protein expression and gene amplification in gastric cancer tissues].
Liu Y; Wang JF; Li XW; Bu P; Bai W; Li LM
Zhonghua Bing Li Xue Za Zhi; 2018 Aug; 47(8):597-602. PubMed ID: 30107664
[No Abstract] [Full Text] [Related]
25. Characteristics of cell lines established from human gastric carcinoma.
Park JG; Frucht H; LaRocca RV; Bliss DP; Kurita Y; Chen TR; Henslee JG; Trepel JB; Jensen RT; Johnson BE
Cancer Res; 1990 May; 50(9):2773-80. PubMed ID: 2158397
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of CD44 and c-erb-B2 protein overexpression in patients with gastric cancer.
Doventas A; Bilici A; Demirell F; Ersoy G; Turna H; Doventas Y
Hepatogastroenterology; 2012 Oct; 59(119):2196-201. PubMed ID: 23435135
[TBL] [Abstract][Full Text] [Related]
27. c-myc Gene amplification in primary stomach cancer.
Koda T; Matsushima S; Sasaki A; Danjo Y; Kakinuma M
Jpn J Cancer Res; 1985 Jul; 76(7):551-4. PubMed ID: 2993214
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of glutathione peroxidase 2 in gastric carcinoma.
Liu D; Sun L; Tong J; Chen X; Li H; Zhang Q
Tumour Biol; 2017 Jun; 39(6):1010428317701443. PubMed ID: 28631563
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of erb-B2 and myc amplification in breast cancer imprints.
Lönn U; Lönn S; Nilsson B; Stenkvist B
Cancer; 1995 Jun; 75(11):2681-7. PubMed ID: 7743470
[TBL] [Abstract][Full Text] [Related]
30. [Amplification of oncogenes in solid tumors in children].
Mares J; Lesková V; Sedlácek Z; Maríková T; Bocek P; Kodet R; Goetz P
Cas Lek Cesk; 1996 Jul; 135(15):493-6. PubMed ID: 8925552
[TBL] [Abstract][Full Text] [Related]
31. Oncogene amplification and expression in pediatric solid tumors.
Mares J; Polanská V; Görgens H; Sedlácek Z; Maríková T; Bocek P; Kodet R; Schackert J; Goetz P
Neoplasma; 1998; 45(3):123-7. PubMed ID: 9717522
[TBL] [Abstract][Full Text] [Related]
32. Analysis of DNA ploidy and proliferative activity in relation to histology and N-myc amplification in neuroblastoma.
Cohn SL; Rademaker AW; Salwen HR; Franklin WA; Gonzales-Crussi F; Rosen ST; Bauer KD
Am J Pathol; 1990 May; 136(5):1043-52. PubMed ID: 2349963
[TBL] [Abstract][Full Text] [Related]
33. Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer.
Paterson MC; Dietrich KD; Danyluk J; Paterson AH; Lees AW; Jamil N; Hanson J; Jenkins H; Krause BE; McBlain WA
Cancer Res; 1991 Jan; 51(2):556-67. PubMed ID: 1670762
[TBL] [Abstract][Full Text] [Related]
34. Amplification of FGFR2 Gene in Patients with Advanced Gastric Cancer Receiving Chemotherapy: Prevalence and Prognostic Significance.
Shoji H; Yamada Y; Okita N; Takashima A; Honma Y; Iwasa S; Kato K; Hamaguchi T; Shimada Y
Anticancer Res; 2015 Sep; 35(9):5055-61. PubMed ID: 26254407
[TBL] [Abstract][Full Text] [Related]
35. An immunohistochemical assessment of cathepsin D in gastric carcinoma: its impact on clinical prognosis.
Allgayer H; Babic R; Grützner KU; Beyer BC; Tarabichi A; Wilhelm Schildberg F; Heiss MM
Cancer; 1997 Jul; 80(2):179-87. PubMed ID: 9217027
[TBL] [Abstract][Full Text] [Related]
36. Recurrent amplification of MYC and TNFRSF11B in 8q24 is associated with poor survival in patients with gastric cancer.
Wang X; Liu Y; Shao D; Qian Z; Dong Z; Sun Y; Xing X; Cheng X; Du H; Hu Y; Li Y; Li L; Dong B; Li Z; Wu A; Wu X; Bu Z; Zong X; Zhu G; Ji Q; Wen XZ; Zhang LH; Ji JF
Gastric Cancer; 2016 Jan; 19(1):116-27. PubMed ID: 25618371
[TBL] [Abstract][Full Text] [Related]
37. MET amplification is not rare and predicts unfavorable clinical outcomes in patients with recurrent/metastatic gastric cancer after chemotherapy.
An X; Wang F; Shao Q; Wang FH; Wang ZQ; Wang ZQ; Chen C; Li C; Luo HY; Zhang DS; Xu RH; Li YH
Cancer; 2014 Mar; 120(5):675-82. PubMed ID: 24804300
[TBL] [Abstract][Full Text] [Related]
38. Amplification of the hst-1 gene in human esophageal carcinomas.
Tsuda T; Nakatani H; Matsumura T; Yoshida K; Tahara E; Nishihira T; Sakamoto H; Yoshida T; Terada M; Sugimura T
Jpn J Cancer Res; 1988 May; 79(5):584-8. PubMed ID: 3136110
[TBL] [Abstract][Full Text] [Related]
39. Gene amplification as a prognostic factor in primary and secondary high-grade malignant gliomas.
Galanis E; Buckner J; Kimmel D; Jenkins R; Alderete B; O'Fallon J; Wang CH; Scheithauer BW; James CD
Int J Oncol; 1998 Oct; 13(4):717-24. PubMed ID: 9735401
[TBL] [Abstract][Full Text] [Related]
40. Long-term survival of patients with stage IV gastric carcinoma.
Kakeji Y; Maehara Y; Tomoda M; Kabashima A; Ohmori M; Oda S; Ohno S; Sugimachi K
Cancer; 1998 Jun; 82(12):2307-11. PubMed ID: 9635521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
